Advertisement
U.S. markets closed
  • S&P 500

    4,594.63
    +26.83 (+0.59%)
     
  • Dow 30

    36,245.50
    +294.61 (+0.82%)
     
  • Nasdaq

    14,305.03
    +78.81 (+0.55%)
     
  • Russell 2000

    1,862.64
    +53.62 (+2.96%)
     
  • Crude Oil

    74.38
    -1.58 (-2.08%)
     
  • Gold

    2,091.70
    +34.50 (+1.68%)
     
  • Silver

    25.90
    +0.24 (+0.92%)
     
  • EUR/USD

    1.0885
    -0.0008 (-0.08%)
     
  • 10-Yr Bond

    4.2260
    -0.1260 (-2.90%)
     
  • GBP/USD

    1.2714
    +0.0086 (+0.68%)
     
  • USD/JPY

    146.7610
    -1.4040 (-0.95%)
     
  • Bitcoin USD

    38,772.98
    +435.55 (+1.14%)
     
  • CMC Crypto 200

    802.76
    +11.20 (+1.41%)
     
  • FTSE 100

    7,529.35
    +75.60 (+1.01%)
     
  • Nikkei 225

    33,431.51
    -55.38 (-0.17%)
     

Silk Road Medical to Present at the UBS MedTech, Tools and Genomics Summit

Silk Road Medical
Silk Road Medical

SUNNYVALE, Calif., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will participate in the upcoming UBS MedTech, Tools and Genomics Summit.

Management is scheduled to present on Thursday, August 17, 2023 at 11:00 a.m. Pacific Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company’s website at: https://investors.silkroadmed.com/.

About Silk Road Medical
Silk Road Medical, Inc. (NASDAQ: SILK), is a medical device company located in Sunnyvale, California, and Plymouth, Minnesota, that is focused on reducing the risk of stroke and its devastating impact. The company has pioneered a new approach for the treatment of carotid artery disease called TransCarotid Artery Revascularization (TCAR). TCAR is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. For more information on how Silk Road Medical is delivering brighter patient outcomes through brighter clinical thinking, visit www.silkroadmed.com and connect on Twitter, LinkedIn and Facebook.

Investor Contact:
Lynn Lewis or Marissa Bych
Gilmartin Group
investors@silkroadmed.com


Advertisement